SM
Shweta Mittal
About Shweta Mittal
Data last updated:
Shweta Mittal is a Director at Kurma Miracle Drugs Private Limited (since 2019) and Director at Nairrti Private Limited (since 2021). The companies operate in Food And Beverages and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹2.76 Cr; the largest is Kurma Miracle Drugs Private Limited at ₹1.45 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kurma Miracle Drugs Private Limited U24304PB2019PTC050318 | Director | 25 Nov 2019 | 2019 | ₹1.45 Cr (FY 2025) | Active |
 Nairrti Private Limited U21002CH2021PTC043653 | Director | 30 Apr 2021 | 2021 | ₹1.32 Cr (FY 2025) | Active |
Board colleagues of Shweta Mittal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rashim Mittal | 08445690 | Kurma Miracle Drugs Private Limited , Nairrti Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shweta Mittal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shweta Mittal
Shweta Mittal currently holds 2 directorships: Kurma Miracle Drugs Private Limited (Director, since 25 Nov 2019, revenue ₹1.45 Cr (FY 2025)); Nairrti Private Limited (Director, since 30 Apr 2021, revenue ₹1.32 Cr (FY 2025)).
Shweta Mittal was first appointed on 25 Nov 2019 as Director at Kurma Miracle Drugs Private Limited. The most recent appointment on record is 30 Apr 2021 at Nairrti Private Limited.
The 2 current companies of Shweta Mittal that report revenue have a combined latest revenue of ₹2.76 Cr: Kurma Miracle Drugs Private Limited ₹1.45 Cr (FY 2025); Nairrti Private Limited ₹1.32 Cr (FY 2025).
The current boards of Shweta Mittal's companies include Rashim Mittal (Kurma Miracle Drugs Private Limited).